Hot Topics | Published:

NMDA-receptor independent actions of ketamine: a new chapter in a story that’s not so old

Neuropsychopharmacologyvolume 44pages220221 (2019) | Download Citation

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Additional information

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. 1.

    Zanos P, Moaddel R, Morris P, Riggs L, Highland J, Georgiou P, et al. Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms. Pharmacol Rev. 2018;70:621-660.

  2. 2.

    Newport D, Carpenter L, McDonald W, Potash J, Tohen M, Nemeroff C. Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression. Am J Psychiatry. 2015;172:950–66.

  3. 3.

    Czysz A, Schappi J, Rasenick M. Lateral diffusion of Gαs in the plasma membrane is decreased after chronic but not acute antidepressant treatment: role of lipid raft and non-raft membrane microdomains. Neuropsychopharmacology. 2014;40:766–73.

  4. 4.

    Wray N, Schappi J, Singh H, Senese N, Rasenick M. NMDAR-independent, cAMP-dependent antidepressant actions of ketamine. Mol Psychiatry. 2018. https://doi.org/10.1038/s41380-018-0083-8.

  5. 5.

    Singh H, Wray N, Schappi J, Rasenick M. Disruption of lipid-raft localized Gαs/tubulin complexes by antidepressants: a unique feature of HDAC6 inhibitors, SSRI and tricyclic compounds. Neuropsychopharmacology. 2018;43:1481–91.

  6. 6.

    Erb S, Schappi J, Rasenick M. Antidepressants accumulate in lipid rafts independent of monoamine transporters to modulate redistribution of the G protein, Gαs. J Biol Chem. 2016;291:19725–19733.

Download references

Funding

NIH: R01AT009169, T32MH067631, R41MH113398, and VA BX001149.

Author information

Affiliations

  1. Departments of Physiology and Biophysics, Psychiatry and the Graduate Program in Neuroscience, University of Illinois College of Medicine, Chicago, IL, 60612, USA

    • Nathan H. Wray
    •  & Mark M. Rasenick
  2. Jesse Brown VAMC, Chicago, IL, 60612, USA

    • Nathan H. Wray
    •  & Mark M. Rasenick

Authors

  1. Search for Nathan H. Wray in:

  2. Search for Mark M. Rasenick in:

Competing interests

M.M.R. has a financial interest in Pax Neuroscience. N.H.W. declares no competing interests.

Corresponding author

Correspondence to Mark M. Rasenick.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/s41386-018-0201-y